COPD: Causes, Symptoms, and Managing Your Condition
Chronic Obstructive Pulmonary Disease (COPD) affects over 16 million Americans and is the third leading cause of death in the United States. Though COPD is not curable, effective management can dramatically reduce symptoms, improve quality of life, and slow disease progression.
Written by
Dr. Maria Fernandez, MD
Cardiology
Medically reviewed by
Dr. Thomas Wright, MD
Board-Certified Pulmonologist
Key Takeaways
- COPD is the #3 cause of death in the US — primarily caused by smoking but preventable
- Quitting smoking at any stage significantly slows progression
- Spirometry is essential for diagnosis and should be performed annually
- Pulmonary rehabilitation improves quality of life more than any single medication
- Action plans for managing exacerbations can reduce hospitalizations by up to 40%
In This Article
What Is COPD?
COPD is an umbrella term for progressive lung diseases — primarily emphysema and chronic bronchitis — characterized by airflow limitation that is not fully reversible. In emphysema, the air sacs (alveoli) are gradually destroyed, reducing the surface area for oxygen exchange and trapping air in the lungs. In chronic bronchitis, the airways are chronically inflamed and produce excess mucus, causing a persistent cough. Most COPD patients have features of both conditions. The disease develops slowly, often over decades, and symptoms may not be noticeable until significant lung damage has occurred. COPD is measured in stages (GOLD 1–4) based on spirometry results — the more severe the airflow limitation, the higher the GOLD stage.
Causes and Risk Factors
Cigarette smoking is the most important risk factor for COPD, responsible for approximately 85–90% of cases. However, up to 15% of COPD cases occur in people who have never smoked. Long-term exposure to occupational dust, chemicals, and fumes (common in mining, agriculture, and construction) is a significant risk factor. Indoor air pollution from burning biomass fuels for cooking and heating is a major COPD driver globally. Genetic factors play a role; alpha-1 antitrypsin deficiency is the best-known genetic cause. A history of severe childhood respiratory infections and asthma also increases COPD risk. Importantly, even former smokers can significantly benefit from quitting at any stage — smoking cessation is the single most effective intervention to slow disease progression.
Diagnosing and Monitoring COPD
Spirometry — a simple breathing test — is the gold standard for diagnosing COPD. It measures how much air you can exhale and how quickly. A post-bronchodilator FEV1/FVC ratio below 0.70 confirms airflow obstruction consistent with COPD. Imaging (chest X-ray or CT scan) can reveal hyperinflation, bullae (air pockets), and other structural changes. Blood tests including arterial blood gas analysis assess how well the lungs are oxygenating the blood. The 6-minute walk test provides practical information about exercise capacity and functional status. Regular monitoring with spirometry every 1–2 years helps track disease progression. The COPD Assessment Test (CAT) and the Modified British Medical Research Council (mMRC) questionnaire quantify symptom burden and guide treatment adjustments.
Treatment: Medications and Pulmonary Rehabilitation
While there is no cure for COPD, treatment significantly reduces symptoms and improves quality of life. Bronchodilators — medications that relax and open the airways — are the cornerstone of COPD treatment. Long-acting bronchodilators (LABAs and LAMAs) are taken daily to maintain airway opening. For patients with frequent exacerbations, inhaled corticosteroids (ICS) combined with bronchodilators reduce inflammation and flare frequency. Oxygen therapy is recommended for patients with severe resting hypoxemia (low blood oxygen). Pulmonary rehabilitation — a comprehensive program of exercise training, education, and psychosocial support — is one of the most effective interventions across all COPD stages, improving exercise capacity and quality of life more than any medication. In select severe cases, surgical options like lung volume reduction surgery or lung transplantation may be considered.
